PSMAddition: A phase 3 trial to compare treatment with (177)Lu-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer Meeting Abstract
| Authors: | Sartor, A. O.; Tagawa, S. T.; Saad, F.; De Bono, J. S.; Feng, F. Y.; Fizazi, K.; Sakharova, O. V.; Morris, M. J. |
| Abstract Title: | PSMAddition: A phase 3 trial to compare treatment with (177)Lu-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900215 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.TPS210 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS210 -- Meeting was conducted online as well as in person -- Source: Wos |
